December 12, 2025

Auna SA (AUNA) Investor Outlook: Exploring a Potential 121% Upside

Auna SA (AUNA), a Luxembourg-based healthcare service provider, is currently capturing the attention of investors with its significant potential upside. With a market cap of $348.6..

iRadimed Corporation (IRMD) Stock Analysis: Exploring Growth in the Medical Device Sector

iRadimed Corporation (NASDAQ: IRMD), a prominent player in the healthcare sector specializing in medical devices, has attracted considerable attention from investors due to its impressive growth..

HealthStream, Inc. (HSTM) Stock Analysis: Unlocking a 39.69% Potential Upside in Healthcare SaaS

Investors eyeing the healthcare sector may find HealthStream, Inc. (HSTM) an intriguing opportunity, particularly with its significant potential upside of 39.69%. As a key player in..

Claritev Corporation (CTEV) Stock Analysis: Healthcare Innovator with 118% Upside Potential

Claritev Corporation (CTEV), a prominent player in the health information services industry, has caught the attention of investors with its compelling growth potential and innovative solutions..

Beta Bionics, Inc. (BBNX) Stock Analysis: High Revenue Growth and Analyst Confidence in Healthcare Innovator

Beta Bionics, Inc. (NASDAQ: BBNX), a frontier player in the medical devices sector, is capturing investor attention with its innovative approach to diabetes management and a..

Akso Health Group (AHG) Investor Outlook: Unpacking the 415% Revenue Surge

For investors seeking opportunities in the healthcare sector, Akso Health Group (NASDAQ: AHG) presents a unique case worth examining. With a staggering 415.80% revenue growth, this..

Delcath Systems, Inc. (DCTH) Stock Analysis: Exploring a 114% Potential Upside for Investors

Delcath Systems, Inc. (NASDAQ: DCTH) is capturing the attention of investors with its promising potential upside of 114.68%. As a key player in the healthcare sector,..

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: A Biotech with 46% Upside Potential

Nurix Therapeutics, Inc. (NASDAQ: NRIX) is poised at the intersection of innovation and opportunity within the biotechnology sector. With its focus on the discovery and development..

Embecta Corp. (EMBC) Stock Analysis: Exploring a 39.47% Potential Upside in the Healthcare Sector

Embecta Corp. (NASDAQ: EMBC) is a noteworthy player in the healthcare sector, particularly the medical instruments and supplies industry. With a market capitalization of $699.23 million,..

uniQure N.V. (QURE) Stock Report: Exploring a Potential 185% Upside in the Biotechnology Sector

In the dynamic world of biotechnology, uniQure N.V. (NASDAQ: QURE) presents a compelling opportunity for investors seeking significant upside potential. With a market capitalization of $1.23..

Tourmaline Bio, Inc. (TRML) Stock Analysis: A Biotech with a Bold Vision and a Niche Market Approach

Tourmaline Bio, Inc. (NASDAQ: TRML) is making waves in the healthcare sector with its focus on developing innovative treatments for immune and inflammatory diseases. With a..

Arvinas, Inc. (ARVN) Stock Analysis: Exploring the Potential of PROTAC Pioneers Amidst Market Volatility

Arvinas, Inc. (NASDAQ: ARVN) stands at the forefront of the biotechnology sector with its innovative approach to drug development, particularly through its pioneering use of PROTAC..

Talkspace, Inc. (TALK) Stock Analysis: Unveiling a 44% Potential Upside with Strong Analyst Support

Talkspace, Inc. (NASDAQ: TALK) is capturing the attention of investors with its impressive potential upside of 44.13%, driven by robust analyst support and a burgeoning footprint..

Valneva SE (VALN) Stock Analysis: Exploring a 43.99% Potential Upside for this French Biotech

Valneva SE (VALN), a dynamic player in the healthcare sector, is making waves in the biotechnology industry with its specialized focus on developing vaccines for infectious..

Immunome, Inc. (IMNM) Stock Analysis: A Promising 31.69% Upside in Biotechnology

Immunome, Inc. (NASDAQ: IMNM) is capturing the attention of biotech investors with its impressive potential upside of 31.69%. As a clinical-stage biotechnology firm, Immunome is well-positioned..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: A 138% Upside Beckons in the Biotech Sector

Niagen Bioscience, Inc. (NAGE), a burgeoning name in the biotechnology sector, is capturing investor attention with its robust growth trajectory and promising market positioning. Headquartered in..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Navigating Potential Amidst a Complex Landscape

Fortrea Holdings Inc. (NASDAQ: FTRE), a burgeoning player in the healthcare sector, particularly within biotechnology, has been capturing investor attention with its strategic collaborations and innovative..

Day One Biopharmaceuticals, Inc (DAWN) Stock Analysis: Exploring a 164% Potential Upside with Innovative Cancer Treatments

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN), a dynamic player in the biotechnology sector, is making waves with its innovative treatments aimed at both childhood and adult..

Evolus, Inc. (EOLS) Stock Analysis: A Compelling Investment Opportunity with 167% Potential Upside

Evolus, Inc. (NASDAQ: EOLS), a burgeoning player in the healthcare sector, specifically within the drug manufacturing space, presents a promising opportunity for individual investors. With a..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Assessing a 37% Potential Upside Amidst Challenging Metrics

The healthcare staffing industry, vital to maintaining the equilibrium in medical care facilities, has faced various challenges recently. In this context, Cross Country Healthcare, Inc. (NASDAQ:..

Search

Funds

December 12, 2025

Search

Funds

December 12, 2025

FTSE 100

Funds